SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (48)9/26/1996 9:12:00 PM
From: Brad C. Dunlap   of 1762
 
Hi Bennett, and Don you should find this interesting as well.

Headlines on a press release over the PR Business Wire: "Cancer patients to protest FDA's disavowal of Clinton/Gore oncology initiatives and lack of FDA reform." The FDA is denying cancer patients access to experimental drugs despite the oncology initiatives announced by the Clinton Administration in March of this year. Patients are also upset over the failure to enact FDA legislative reforms in the 104th Congress. Representative Frank Pallone, Jr. (D-NJ) will discuss the access to medial treatment act legislation that would allow patients expanded access to the treatment of their choice in experimental drugs and therapies. The access to medical treatment act (s. 1035 HR2019) has many bipartisan congressional co-sponsors but has not been enacted by the 104th Congress.

"The FDA has broken it's word again" said Siegel. "While the Onoclogy initatives did not change current law, the initiatives were a statement of intent by the Clinton Administration to expedite the approval process for new cancer drugs and allow patients expanded access to experimental cancer drugs. Antineoplastons meet that criteria. It is clear to us that the FDA has no concern for cancer patients, particularly Dr. Burzynski's. Again this agency has chosen politics over science and disobeys the policies set forth by this Administration to help cancer patients."

I wouldn't be surprised to hear more rhetoric of this sort in the future and is certainly a positive for potential cancer drugs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News